1.159 articles found

Efficacy and Safety of MAO-B Inhibitors Safinamide and Zonisamide in Parkinson's Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Aboulatta L, Haidar L, Abou-Setta A, Askin N, Rabbani R, Lavu A, Peymani P, Zarychanski R, Eltonsy S.

CNS Drugs · 2023-11-16

DOI: 10.1007/s40263-023-01048-xPMID: 37973769

Movement Sonification Techniques to Improve Balance in Parkinson's Disease: A Pilot Randomized Controlled Trial.

Raglio A, De Maria B, Parati M, Giglietti A, Premoli S, Salvaderi S, Molteni D, Ferrante S, Dalla Vecchia LA.

Brain Sci · 2023-11-12

DOI: 10.3390/brainsci13111586PMID: 38002546

Effect of Proprioceptive Training Compared With Other Interventions for Upper Limb Deficits in People With Parkinson Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

Malwanage KT, Dissanayaka TD, Allen NE, Paul SS.

Arch Phys Med Rehabil · 2023-11-10

DOI: 10.1016/j.apmr.2023.10.016PMID: 37951376

A Longitudinal Two-Armed Randomized Controlled Trial Protocol to Evaluate the Efficacy of Yoga on Progression of Disease in Early Parkinson's Disease.

Some P, Majumdar V, N K M, Shetty K, Snigdha A.

Ann Neurosci · 2023-11-07

DOI: 10.1177/09727531231198298PMID: 40303506

Movement Sonification Techniques to Improve Balance in Parkinson’s Disease: A Pilot Randomized Controlled Trial

Raglio A, De Maria B, Parati M, Giglietti A, Premoli S, Salvaderi S, Molteni D, Ferrante S, Dalla Vecchia L.

Brain sciences · 2023-11-01

Randomized controlled trial of KW-6356 monotherapy in patients with early untreated Parkinson's disease.

Maeda T, Kimura T, Sugiyama K, Yamada K, Hiraiwa R, Nishi M, Hattori N, 6356-002 study group.

Parkinsonism Relat Disord · 2023-10-31

DOI: 10.1016/j.parkreldis.2023.105907PMID: 37948832

Effects of physical exercise interventions on cognitive function in Parkinson's disease: An updated systematic review and meta-analysis of randomized controlled trials.

Kim R, Lee TL, Lee H, Ko DK, Lee JH, Shin H, Lim D, Jun JS, Byun K, Park K, Jeon B, Kang N.

Parkinsonism Relat Disord · 2023-10-26

DOI: 10.1016/j.parkreldis.2023.105908PMID: 37922635

Effects of high-intensity interval training and moderate-intensity continuous training on sarcopenia-related parameters in participants with Parkinson's disease: A 24-week randomized pilot trial substudy.

Kim R, Choi S, Kang N, Park K, Shin H, Lee H, Lee H, Jun JS, Jeon B, Byun K.

Parkinsonism Relat Disord · 2023-10-21

DOI: 10.1016/j.parkreldis.2023.105901PMID: 37898016

Efficacy of non-immersive virtual reality-based telerehabilitation on postural stability in Parkinson's disease: a multicenter randomized controlled trial.

Goffredo M, Baglio F, DE Icco R, Proietti S, Maggioni G, Turolla A, Pournajaf S, Jonsdottir J, Zeni F, Federico S, Cacciante L, Cioeta M, Tassorelli C, Franceschini M, Calabrò RS, RIN_TR_Group.

Eur J Phys Rehabil Med · 2023-10-17

DOI: 10.23736/s1973-9087.23.07954-6PMID: 37847247

Tailored interventions to improve adherence to medication in elderly patients with Parkinson's disease: a study protocol for a randomized controlled trial (AdhCare).

Mendorf S, Teschner U, Lehmann T, Prell T, Mühlhammer HM.

Trials · 2023-10-12

DOI: 10.1186/s13063-023-07663-9PMID: 37828583

Significant potential of melatonin therapy in Parkinson's disease - a meta-analysis of randomized controlled trials.

Iftikhar S, Sameer HM, Zainab.

Front Neurol · 2023-10-10

DOI: 10.3389/fneur.2023.1265789PMID: 37881313

Neuroimaging and serum biomarkers of neurodegeneration and neuroplasticity in Parkinson's disease patients treated by intermittent theta-burst stimulation over the bilateral primary motor area: a randomized, double-blind, sham-controlled, crossover trial study.

Rashid-López R, Macías-García P, Sánchez-Fernández FL, Cano-Cano F, Sarrias-Arrabal E, Sanmartino F, Méndez-Bértolo C, Lozano-Soto E, Gutiérrez-Cortés R, González-Moraleda Á, Forero L, López-Sosa F, Zuazo A, Gómez-Molinero R, Gómez-Ramírez J, Paz-Expósito J, Rubio-Esteban G, Espinosa-Rosso R, Cruz-Gómez ÁJ, González-Rosa JJ.

Front Aging Neurosci · 2023-10-05

DOI: 10.3389/fnagi.2023.1258315PMID: 37869372